Conference Coverage
Latest News
Jul 22, 2026 | Feature
Sunscreen’s New Blind Spot: Fashion Trends, Tanning Myths, and the Rise of Gluteal Melanomas
TNF Inhibitors Linked to Increased Skin Cancer Risk in Long-Term Cohort Study
Jul 22, 2026
Journal Digest: July 22, 2026
Jul 22, 2026
Referral Barriers Persist in Advanced Cutaneous Squamous Cell Carcinoma Care
Jul 21, 2026
EADV Review Finds Major Safety and Transparency Gaps in Mobile AI Dermatology Apps
Jul 21, 2026
Videos
Advertisement
Shorts
0:33
Stop Using 'Adaptive Trials' as Just a Buzzword
5 hours ago
by
Bradley Burnam
0:21
One Night Of Bad Sleep Ruins Your Skin
a day ago
by
Peter Lio, MD
0:24
How to Find the Best Sunscreen for Each Patient
2 days ago
by
Kathleen Suozzi, MD
0:25
Proving safety in new drug trials.
2 days ago
by
Bradley Burnam
0:41
The Dangers of Decreasing Injection Frequency Too Fast
4 days ago
by
Jennifer Soung, MD
0:48
Is oral minoxidil safe for hair loss?
5 days ago
by
Adam Friedman, MD, FAAD
0:23
AI Models May Improve Risk Prediction in Early-Stage Melanoma
6 days ago
by
Eugene R. Semenov, MD, MA, FAAD,
0:36
Lasers and DNA: How skin treatments impact cancer biology
6 days ago
by
Konika Patel Schallen, MD
0:35
A New Way to Treat Atopic Dermatitis?
7 days ago
by
Raj Chovatiya, MD, PhD, MSCI
0:36
Stop Using the Word 'Robust' in Dermatology
8 days ago
by
Christopher G. Bunick, MD, PhD
GEP-Guided Treatment for Melanoma & SCC Management
New Insights in Management of Moderate Hidradenitis Suppurativa
Discover Dermatology Times NP/PA Connect™!
Personalizing Treatment for Difficult Atopic Dermatitis Cases
Connect With Dermatology Times® Wherever You Scroll
Podcasts
Dermatology Times Digital Edition
New trends around cheeky swimwear and tanning myths are leading to rising rates of melanomas in sensitive areas; read July's cover story to learn more.
Learn more about the in-depth topics covered in the June 2026 print issue of Dermatology Times.
Lim considers mentoring and helping develop the next generation of dermatologists one of his most meaningful contributions to the specialty.
Andrew Krakowski, MD, encourages involving both caregivers and children in treatment decisions, giving young patients a sense of ownership that can significantly improve adherence.
New data show that nearly two-thirds of Sun Bus participants had never visited a dermatologist, highlighting persistent gaps in access to skin cancer care.
Career decisions in dermatology are too often driven by emotion rather than data, according to a new practice management column examining common pitfalls in contract evaluation and compensation negotiations.
Innovations in packaging, formulation design, and alternative preservation strategies may reduce preservative concentrations, but they are unlikely to eliminate the need for preservatives entirely.
Data from the BroADen trial suggest that targeting STAT6 through protein degradation may offer a novel oral approach to controlling type 2 inflammation in atopic dermatitis.
Because BCC and cSCC have high tumor mutational burdens driven by UV-induced DNA damage, they are particularly well suited to immune checkpoint inhibition.
In clinical practice, digital twins could predict how individual patients respond to treatments based on factors such as genetics, skin barrier function, and lifestyle patterns.
Continuing Medical Education
All News
Advertisement
Advertisement
Real-world TARGET-DERM data show switching to upadacitinib boosts skin clearance, itch relief and quality of life for tough atopic dermatitis.
NPF guidance outlines patient selection, counseling, and multidisciplinary management of GLP-1 receptor agonists in psoriasis.
IEC modified Delphi process establishes standardized treatment targets for atopic dermatitis
New research shows bakuchiol ferulate mimics retinol’s skin-renewal effects while boosting light and heat stability, lowering phototoxicity, and improving irritation tolerance in tests.
In a recent study, low-fluence fractional 694‑nm ruby laser safely lightened stubborn melasma, while AI imaging tracked subtle pigment and texture improvements missed clinically.
A JAMA Dermatology study found expert dermatologists achieved the highest multiclass diagnostic accuracy when tested against AI across a realistic spectrum of skin lesions.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Do patients really need to stop using retinoids in the summer or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
Dermatologists and oncologists at a Dermatology Times Evolving Paradigms event in Dallas compared immunotherapy selection, adverse event management, and referral practices in advanced cutaneous squamous cell carcinoma.
Placebo-arm RCTs show gentle cleansing, moisturizing, and sunscreen alone can significantly improve acne, rosacea, AKs, melasma, and PIH, boosting outcomes beyond prescriptions.
Advertisement
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
New phase 3 data presented at the AAD Innovation Academy show zasocitinib achieved high rates of clear or almost clear skin at the scalp, palms, soles, and nails at week 16.
Anatomy-guided VectorLift thread lift cuts pain and downtime, lowers bruising risk, and delivers comparable facial lifting in real-world patient study.
New phase 3 data show oral TYK2 inhibitor soficitinib improves moderate-to-severe atopic dermatitis, easing itch with no new safety signals.
Extended-release oral minoxidil candidate VDPHL01 improved hair counts and patient-reported outcomes in women with pattern hair loss in a phase 2 study.
Advertisement
Advertisement
Trending on Dermatology Times
1
Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD
2
New Consensus Defines Remission, Disease Activity in Atopic Dermatitis
3
How Dermatologists Can Incorporate GLP-1 Receptor Agonists Into Psoriasis Care
4
Systemic JAK Inhibitors for Vitiligo: Emerging Clinical Trial Data and Safety Considerations
5